Skip to main content

BROWN ADVISORY INC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1345929 BALTIMORE, MD

Position in HALO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,341,221
-$72,830 QoQ
Shares Held
36,225
+1.0% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.67425810904072.ToString("F0")% Shared 0.ToString("F0")% None 0.3257418909592823.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BROWN ADVISORY INC holds $209,016,512 across 24 Biotechnology names. HALO ranks #8 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 HALO
Halozyme Therapeutics, Inc.
This page
36,225 $2,341,221

All Filings in HALO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,341,221 36,225
2025-12-31 $2,414,051 35,870
2025-09-30 $2,564,333 34,965
2025-06-30 $1,823,665 35,057
2025-03-31 $2,222,693 34,833
2024-12-31 $1,905,945 39,865
2024-09-30 $1,194,198 20,863
2024-06-30 $1,091,391 20,844
2024-03-31 $847,933 20,844
2023-12-31 $774,681 20,960
2023-09-30 $794,980 20,811
2023-06-30 $750,652 20,811
2023-03-31 $794,772 20,811
2022-12-31 $2,356,399 41,413
2022-09-30 $1,637,470 41,413
2022-06-30 $1,822,172 41,413
2022-03-31 $1,651,550 41,413
2021-12-31 $1,670,082 41,534
2021-09-30 $1,685,453 41,432
2021-06-30 $1,880,564 41,413
2021-03-31 $2,601,581 62,403
2020-12-31 $2,666,812 62,440
2020-09-30 $1,638,084 62,332
2020-06-30 $965,964 36,030
2020-03-31 $648,179 36,030